Stay updated on Nivolumab with Radiation and Androgen Deprivation Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Radiation and Androgen Deprivation Clinical Trial page.

Latest updates to the Nivolumab with Radiation and Androgen Deprivation Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No substantive changes to study details or page content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedTimeline fields updated to show estimated dates: Primary Completion (Estimated) 2026-06-01, Study Completion (Estimated) 2026-12, and Enrollment (Estimated) 44, with older 'Actual' dates removed.SummaryDifference0.3%

- Check31 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No study details or user-facing content appear to be affected.SummaryDifference0.1%

- Check39 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3, indicating an updated deployment with no changes to study content.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision: v3.4.2 has been added and the previous notice regarding government funding (v3.4.1) has been removed. The core study details, eligibility criteria, and trial information remain unchanged.SummaryDifference0.4%

- Check74 days agoChange DetectedIntroduced a site-wide notice about a lapse in government funding and NIH Clinical Center operations, directing users to cc.nih.gov and opm.gov for updates. Updated revision history to v3.4.1 (2026-01-29), with deletions of v3.4.0 entries.SummaryDifference0.8%

Stay in the know with updates to Nivolumab with Radiation and Androgen Deprivation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Radiation and Androgen Deprivation Clinical Trial page.